These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23826229)
1. Addition of rapamycin to anti-CD3 antibody improves long-term glycaemia control in diabetic NOD mice. Perl S; Perlman J; Weitzel RP; Phang O; Hsieh MM; Tisdale J PLoS One; 2013; 8(6):e67189. PubMed ID: 23826229 [TBL] [Abstract][Full Text] [Related]
2. Rapamycin prevents and breaks the anti-CD3-induced tolerance in NOD mice. Valle A; Jofra T; Stabilini A; Atkinson M; Roncarolo MG; Battaglia M Diabetes; 2009 Apr; 58(4):875-81. PubMed ID: 19151201 [TBL] [Abstract][Full Text] [Related]
3. Anti-CD3 antibody treatment induces hypoglycemia and super tolerance to glucose challenge in mice through enhancing glucose consumption by activated lymphocytes. Xia CQ; Chernatynskaya AV; Looney B; Wan S; Clare-Salzler MJ J Immunol Res; 2014; 2014():326708. PubMed ID: 24741590 [TBL] [Abstract][Full Text] [Related]
4. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice. Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y Am J Pathol; 2008 Apr; 172(4):972-9. PubMed ID: 18349126 [TBL] [Abstract][Full Text] [Related]
5. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation. Ablamunits V; Henegariu O; Hansen JB; Opare-Addo L; Preston-Hurlburt P; Santamaria P; Mandrup-Poulsen T; Herold KC Diabetes; 2012 Jan; 61(1):145-54. PubMed ID: 22043003 [TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor necrosis factor in anti-CD3 antibody stimulated diabetic NOD mice: modulation by PGE1 and dietary lipid. Barel D; Brennan DC; Jevnikar AM; Bastos M; Strom TB; Kelley VR Autoimmunity; 1992; 13(2):141-9. PubMed ID: 1467435 [TBL] [Abstract][Full Text] [Related]
7. Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease. Ma H; Lu Y; Li H; Campbell-Thompson M; Parker M; Wasserfall C; Haller M; Brantly M; Schatz D; Atkinson M; Song S Diabetologia; 2010 Oct; 53(10):2198-204. PubMed ID: 20593162 [TBL] [Abstract][Full Text] [Related]
8. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522 [TBL] [Abstract][Full Text] [Related]
9. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239 [TBL] [Abstract][Full Text] [Related]
10. Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes. Baeke F; Van Belle TL; Takiishi T; Ding L; Korf H; Laureys J; Gysemans C; Mathieu C Diabetologia; 2012 Oct; 55(10):2723-2732. PubMed ID: 22752077 [TBL] [Abstract][Full Text] [Related]
11. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies. Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley AN Transpl Immunol; 2002 Jun; 10(1):63-72. PubMed ID: 12182467 [TBL] [Abstract][Full Text] [Related]
12. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Chatenoud L; Thervet E; Primo J; Bach JF Proc Natl Acad Sci U S A; 1994 Jan; 91(1):123-7. PubMed ID: 8278351 [TBL] [Abstract][Full Text] [Related]
13. Oral anti-CD3 monoclonal antibody delays diabetes in non-obese diabetic (NOD) mice: effects on pregnancy and offspring--a preliminary report. Bevier WC; Trujillo AL; Primbs GB; Bradley MK; Jovanovič L Diabetes Metab Res Rev; 2011 Jul; 27(5):480-7. PubMed ID: 21484981 [TBL] [Abstract][Full Text] [Related]